Market Research Blog – Page 985 – New Product Development

Enterprise Feedback Management Market to Grow at 18.1% CAGR, Surpassing US$ 14.09 Billion by 2034

The Enterprise Feedback Management Market for 2023 to 2033 is projected to witness rapid expansion, according to a new report. The market is forecasted to grow from US$ 2,677.5 million in 2024 to US$ 14,096.8 million by 2034, representing a compound annual growth rate (CAGR) of 18.1%. The increasing importance of customer feedback in shaping business strategies and enhancing customer experiences is driving the demand for enterprise feedback management solutions.

Enterprise feedback management (EFM) software allows organizations to capture, analyze, and act on customer and employee feedback in real time. This enables businesses to improve product offerings, enhance customer satisfaction, and foster a culture of continuous improvement.

Key Takeaways from Market Study

The enterprise feedback management market is expected to grow to US$ 14,096.8 million by 2034.
A robust 18.1% CAGR is projected from 2024 to 2034.
The rise in demand for real-time customer insights and personalized experiences is driving market growth.
Cloud-based EFM solutions are expected to dominate due to their scalability and cost-efficiency.

Drivers and Opportunities
The increasing focus on customer-centric strategies and the growing adoption of digital technologies are key drivers for the enterprise feedback management market. Businesses across industries are recognizing the value of real-time feedback in improving customer experiences, optimizing operations, and building long-term relationships.

Opportunities abound for market players to integrate artificial intelligence (AI) and machine learning (ML) into EFM platforms, enabling predictive analytics and sentiment analysis. These advancements allow businesses to uncover actionable insights, anticipate customer needs, and enhance decision-making processes.

Components Insights
The enterprise feedback management market is segmented into software and services. The software segment is anticipated to dominate, driven by the growing adoption of cloud-based and AI-powered platforms that offer advanced analytics and user-friendly interfaces. The services segment, which includes consulting, support, and training, is also expected to grow steadily as organizations seek expert guidance on maximizing the value of their feedback management systems.

Application Insights
EFM solutions find applications across a range of industries, including retail, healthcare, financial services, and hospitality. The retail sector is expected to be a major contributor to market growth, as businesses leverage feedback management systems to improve customer loyalty, optimize product offerings, and personalize marketing efforts. The healthcare sector is also expected to see strong adoption, with EFM solutions being used to enhance patient satisfaction and improve service delivery.

Deployment Insights
Cloud-based enterprise feedback management solutions are gaining traction due to their scalability, flexibility, and lower costs. Cloud deployments allow businesses to easily expand their feedback management systems and integrate them with other enterprise tools, making it easier to capture and analyze feedback across multiple channels. On-premise solutions, while still relevant for large enterprises with stringent data security requirements, are expected to see slower growth compared to cloud-based options.

Key Companies & Market Share Insights
Leading players in the enterprise feedback management market include Qualtrics, Medallia, Inc., Verint Systems Inc., Confirmit, and InMoment. These companies are investing heavily in research and development to provide innovative solutions that help businesses capture meaningful customer insights and drive better decision-making. Strategic partnerships, product enhancements, and mergers and acquisitions are common strategies employed by key players to expand their market presence.

Recent Developments

Qualtrics recently launched an AI-driven customer experience management platform that allows businesses to analyze feedback more effectively and provide personalized responses in real time.
Medallia, Inc. introduced a new cloud-based feedback management solution that integrates with popular CRM systems, allowing businesses to create a seamless customer feedback loop.
Verint Systems Inc. announced a partnership with leading retail brands to deploy AI-powered feedback management tools designed to improve customer loyalty and retention.

As the need for real-time customer insights and actionable feedback grows, the enterprise feedback management market is expected to witness substantial growth over the next decade. The integration of advanced technologies such as AI and predictive analytics will further enhance the value of EFM solutions, providing businesses with deeper insights and improved operational efficiency.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Vaginal and Vulval Inflammatory Diseases Treatment Market Projected to Reach USD 5.21 Billion by 2033 at a 5.8% of CAGR, Driven by Steady Growth and Increased Awareness

The global vaginal and vulval inflammatory diseases treatment market is expected to be valued at USD 2.96 Billion in the fiscal year 2023, up from USD 2.8 Billion in 2022. With a steady CAGR of 5.8% anticipated from 2023 to 2033, the market is projected to reach approximately USD 5.21 Billion by the end of the forecast period.

This growth is indicative of the increasing awareness and focus on women’s health issues, alongside the continuous development of effective treatments for vaginal and vulval inflammatory diseases. As healthcare providers and pharmaceutical companies enhance their offerings, patients will benefit from improved therapeutic options, contributing to the overall expansion of this vital market segment. The sustained investment in research and development further underscores the commitment to addressing the needs of women affected by these conditions.

Both vulvitis (vulval inflammation) and vaginitis (vaginal inflammation) refer to inflammation of the female reproductive organs. Vulvitis is an infection of the genitals, or vulva – the outermost portion of the female reproductive anatomy. Vaginitis is an inside-the-body inflammation that damages the vagina. Vulvovaginitis is an inflammation that affects both the vulva and the vagina. These inflammatory disorders are typically brought on by yeast, candida species, or candida Albicans. Atypical vaginal discharge, dyspareunia, external dysuria, vaginal discomfort, and pruritis are a few signs of vaginal and vulval inflammation.

Approximately 75% of women are expected to have vaginal and vulval inflammation at least once, and 42% to 45% of women may experience the illness twice or more, according to statistics from the Centers for Disease Control and Prevention. Depending on the clinical presentation, the microbiology, the host characteristics, and the response to treatment, this illness is categorized as difficult or simple.

In most cases, the problem necessitates consulting a gynecologist or simply a nurse practitioner. Antifungal drugs can be used to diagnose and treat vaginal and vulval irritation. Although vaginal and vulval inflammation may usually be managed in a few days, more serious instances may require extended periods of therapy. Such factors have been boosting the treatment market for vaginal and vulval inflammations during the forecast period.

Competitive Landscape

Some of the prominent players in the global market for vaginal and vulval inflammatory diseases treatment are:

Almirall
VenusConcept
ThermiGen LLC
Lutronic
BTL Group of Companies
Viveve
Fotona
Evofem Biosciences, Inc.
Spero Therapeutics
Hologic
Kyung Hee University Hospital

Some of the prominent developments of the key players in the market are:

Evofem Biosciences, Inc. presented additional results from the Phase 3 EMPOWER clinical study of Phexxi (lactic acid, citric acid, and potassium bitartrate) in May 2022, revealing that women who participated in the EMPOWER trial had fewer urinary tract infections (UTIs) than the general population. In order to fill immediate needs in women’s reproductive and sexual health, Evofem Biosciences, Inc. is creating and marketing novel solutions, such as hormone-free, woman-controlled contraception and gonorrhea and chlamydia protection. Phexxi® (lactic acid, citric acid, and potassium bitartrate), the company’s first FDA-approved medication, is a hormone-free, prescription-only vaginal gel contraception.
The US Food and Drug Administration (USFDA) approved Priority Review for Spero Therapeutics’ tebipenem HBr (tebipenem pivoxil hydrobromide) New Drug Registration in January 2022 for the therapy of individuals with complex urinary tract infections (cUTI) as well as inflammations, especially pyelonephritis, caused by sensitive bacteria.

Key Companies Profiled

Almirall
VenusConcept
ThermiGen LLC
Lutronic
BTL Group of Companies
Viveve
Fotona
Hologic
Kyung Hee University Hospital

A Full Report Overview

Key Segments Covered In The Vaginal And Vulval Inflammatory Diseases Treatment Market Report

Vaginal And Vulval Inflammatory Diseases Treatment Market By Indication:

Vaginal Dryness
Vaginal Burning
Vaginal Discharge
Genital Itching
Recurrent Urinary Tract Infections
Urinary Incontinence
Others

Vaginal And Vulval Inflammatory Diseases Treatment Market By Treatment:

Anti-Itch Medications
Corticosteroid Ointments
Anti-Itch Emollients

Vaginal And Vulval Inflammatory Diseases Treatment Market By End User:

Hospital Pharmacies
Specialty Clinics
Others

Vaginal and Vulval Inflammatory Diseases Treatment Market By Region:

North America
Latin America
Asia Pacific
Europe
Middle East & Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Mooring Compensators Market Projected to Reach USD 2439 Million by 2032, Driven by Durability and Customization

The global mooring compensators market is currently valued at USD 1780 million and is expected to grow to USD 2439 million by 2032, achieving a CAGR of 3.2% from 2022 to 2032.

Mooring equipment is typically made from propylene rubber, known for its resistance to sunlight and ozone. Mooring compensators play a crucial role in extending the lifespan of mooring lines by absorbing excess tension, thereby reducing stress on cleats.

One of the key advantages of mooring compensators is that their installation requires no specialized skills, making them a cost-effective solution to alleviate the load on boat lines. This characteristic is likely to boost the sales of mooring compensators in the coming years.

Available in a variety of sizes, mooring compensators can be customized to meet specific needs. Recent technological advancements are being applied to enhance existing metal mooring compensators, which are prone to rust and can operate noisily. As a result, rubber-based mooring compensators are increasingly favored for their durability and quieter operation.

Mooring compensators can be adjusted based on the number of times the line wraps around them, allowing for extensions with more turns. Additionally, no extra fittings are required, as locking elements are integrated at both ends and vulcanized into the compressor. These features are set to significantly impact the mooring compensators market in the near future.

Rubber-based mooring compensators are resistant to corrosion, contributing to a longer lifecycle, and their lightweight properties help dampen noise.

However, it is important to note that manufacturing costs may rise due to supply chain disruptions caused by the ongoing Russia-Ukraine war, along with conflicts between Azerbaijan and Armenia, which have led to a shortage of raw materials.

Key Takeaways from Mooring Compensators Market

North America holds 28% of the market share, which could be reasoned with sizable population engaging in hordes of fun activities like fishing, boating, and likewise. Plus, safety rendered by the mooring compensators is unparalleled. This has reposed faith regarding mooring compensators amongst manufacturers.
Europe holds 31% of the market share. This could be attributed to the region being aa hub of majority of boat manufacturing companies that use advanced machines, motors, and the other watercraft accessories. Metal-based compensators are not much to be seen as they are noisy. As such, rubber-based mooring compensators are expected to be the norm going forward.

Competitive Compensators

Trelleborg, in September 2022, committed itself toward achievement of sustainability via designing tailor-made solutions.
Unimer Marine, in November 2021, participated in METSTRADE Marine Equipment Tradeshow.
Anchor Marine’s mooring compensator is meant for Ø 10-12 mm with EPDM rubber for boats upto 20 ft. (6 mm).
Teijin Aramid’s products constitute high class aramid fibers that do offer superlative results and long lasting value.

Key Segments in the Mooring Compensators Market

By Material:

Rubber-baseded
Polyurethane based

By Product Type:

U-Cleat Mooring Compensator
Smart Snubber Mooring Compensator
Inline Mooring Compensator
Classic Mooring Compensator
Others

By Mooring Type:

Catenary
Taut
Semi Taut
Spread
Single Point
Dynamic Positioning

Report Preview: https://www.futuremarketinsights.com/reports/mooring-compensators-market

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Energy Portfolio Management Market 2023 Future Analysis, Demand by Regions and Opportunities with Challenges 2033

The energy portfolio management market is estimated to reach US$ 12,947.66 million by 2033, surging from US$ 4,022.80 million in 2023.

The growing popularity of the adoption of renewable energy sources creates many opportunities in the energy portfolio management market. But energy portfolio management solutions are expensive, creating barriers for small and entry-level businesses. As the energy market is constantly changing, which is a threat to the energy portfolio management market.

Market Opportunities

The energy portfolio management market is growing with an impressive CAGR value of 12.4%, which creates many opportunities to grow in this market. There is a growing adoption of renewable energy sources like solar and wind power, which creates opportunities in the energy portfolio management market.

Many businesses are focusing on sustainability, and energy portfolio management helps businesses to offer sustainability goals and also helps companies to save money on their energy bills.

Total Valuation of Energy Portfolio Management Systems:
- The global energy portfolio management market is valued at approximately US$ 4,022.8 million in 2023.
Leading End-user Segment:
- In 2022, the industrial sub-type segment was the leading end-user segment, generating the highest revenue in the energy portfolio management market.
Market Share of Europe:
- Europe accounted for about 20.6% of the global energy portfolio management market in 2022.
Contribution of North America:
- North America contributed 32.6% to the global energy portfolio management market revenue in 2022, making it a significant player in the market.
Leading Challenge for the Market:
- One of the primary challenges facing the energy portfolio management market is the high implementation and deployment costs, which could hinder widespread adoption.

Key Takeaways

The energy portfolio management market is expected to grow from an estimated US$ 4,022.80 million in 2023 to US$ 12,947.66 million by 2033.
The energy portfolio management market is expected to record a CAGR of 12.4% from 2023 to 2033, driven by the increasing demand for energy efficiency and the growing adoption of renewable energy sources.
India is a leading market for energy portfolio management due to the government’s focus on sustainable energy and the growing demand for energy security.
China is the leading energy portfolio management market driven by the country’s rapid economic growth and the need to reduce its reliance on fossil fuels.
Europe is a growing market for energy portfolio management, in which businesses look for ways to reduce their carbon emissions and meet their sustainability goals.
North America is a mature market for energy portfolio management. However, there is still room for growth as businesses adopt new technologies and strategies to manage their energy portfolios sustainably.

Competitors Winning Strategies

Competitors in the energy portfolio management market are working on many strategies, such as making new products and services for offering their customers in a new way, and it is also important for businesses, so they are investing in this. They are partnering with other firms and markets; with this, they get a wider range of services to offer their customers. Also with this, they get new customers from other markets.

They are also focusing on customer service and trying to give 24/7 service, which is also important as it helps customers clear their issues and queries and helps them get loyal customers.

ABB, Cisco, EnerNOC, Google Cloud, IBM, Schneider Electric, and Uplight are some energy portfolio management market competitors.

Recent Developments

ABB:Acquired Green Mountain Energy, a leading United States renewable energy supplier, to extend its energy portfolio management solutions.
Cisco:Partnered with Schneider Electric, a prominent energy management solutions supplier, to create innovative energy portfolio management solutions.
Google Cloud:Launched a new energy portfolio management solution to assist organizations handle energy portfolios in the cloud.
Microsoft:Worked with Uplight, a renowned energy management software supplier, to offer new energy portfolio management solutions for Microsoft Azure clients.

Key Segments Covered In The Energy Portfolio Management Industry Analysis

Energy Portfolio Management Market by End User:

Residential
Industrial
Commercial

Energy Portfolio Management Market by Deployment:

Cloud
On-premises

Energy Portfolio Management Market by Region:

North America
Latin America
Europe Energy
Asia Pacific Energy
The Middle East & Africa

About Future Market Insights (FMI)

Contact Us:

Global Progressive Fibrosing Interstitial Lung Disease Market Projected to Reach USD 8654.1 Million by 2033 at a 6.2% of CAGR

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is anticipated to expand at a CAGR of 6.2% during the forecast period from 2023 to 2033. This growth trajectory is expected to propel the market to an impressive USD 8,654.1 Million by 2033.

The rise in the PF-ILD market can be attributed to several key factors, including increased awareness of the disease and the anticipated launch of innovative therapies. As healthcare technology continues to advance, stakeholders are optimistic about improved diagnostic and treatment options that can enhance patient outcomes. With these developments, the market for Progressive Fibrosing Interstitial Lung Disease is poised for significant growth in the coming years, reflecting a broader trend towards addressing unmet medical needs in respiratory care.

The progressive fibrosing interstitial lung disease market is anticipated to increase due to factors such as increased awareness of PF-ILD along with the expected launch of emerging therapies during the forecast period (2023 to 2033).

Progressive Fibrosing Interstitial Lung Disease (PF-ILD) consists of a diverse group of interstitial lung diseases (ILDs) characterized by a similar clinical phenotype of accelerated respiratory failure, frequent disease exacerbation, and earlier mortality.

Interstitial lung disease is believed to be caused by long-term exposure to hazardous materials, such as asbestos or coal dust, or it can be caused by an auto-immune disease such as rheumatoid arthritis. Progressive Fibrosing Interstitial Lung Diseases are composed of Idiopathic Interstitial Pneumonias such as non-specific interstitial pneumonia and unclassifiable interstitial pneumonia, and inhalation lung diseases such as chronic hypersensitivity pneumonia, and connective tissue disease-associated ILD such as rheumatoid arthritis-related ILD and SSc-related ILD, and sarcoidosis and so on. Many interstitial lung diseases (ILDs) are characterized by chronic progressive fibrosis.

The type-specific segmentation majorly includes Idiopathic Interstitial Pneumonias (IIPs), Autoimmune ILDs, Hypersensitivity Pneumonitis, Sarcoidosis, and ILDs.
Imaging tests such as X-ray and a high-resolution computed tomography (CT scan), are key to, and sometimes the first step in, the diagnosis of interstitial lung disease. The severity level of Progressive Fibrosing Interstitial Lung Disease is calculated on the basis of the FVC score. However, identifying and determining the cause of interstitial lung disease can be challenging, as a large number of disorders fall into this broad category. Hence differential diagnosis is needed.

Competitive Landscape

Some of the key players present in the global progressive fibrosing interstitial lung diseases treatment markets are Boehringer Ingelheim, Bristol-Myers Squibb, FibroGen, Hoffmann-La Roche Ltd, Pliant Therapeutics, Inc., United Therapeutics, Vicore Pharma AB, Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, GNI-EPS Pharmaceuticals, Inc. and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, applications, and industries.

In February 2022, Boehringer Ingelheim announced that the USA Food and Drug Administration (FDA) granted Breakthrough Therapy Designation to its novel investigational therapy, BI 1015550, for the treatment of idiopathic pulmonary fibrosis (IPF). BI 1015550 is an oral, phosphodiesterase 4B (PDE4B) inhibitor with the potential to address both pulmonary fibrosis – irreversible scarring of lung tissue that negatively impacts lung function – and inflammation associated with progressive fibrosing interstitial lung diseases (ILDs)

FibroGen is developing pamrevlumab (also known as FG-3019), an intravenously administered, first-in-class, a fully-humanized monoclonal antibody that inhibits the activity of connective tissue growth factor activity, or CTGF, a critical mediator in the progression of fibrosis and related serious diseases. Other than IPF, FibroGen is also evaluating Pamrevlumab in Phase III clinical development for the treatment of Duchenne muscular dystrophy (DMD), and locally advanced unresectable pancreatic cancer (LAPC). Furthermore, as stated by the company, the drug demonstrated the potential for stabilization of disease and reversal of lung fibrosis in some patients.
In March 2020 – Roche announced that the USA Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Esbriet® (pirfenidone) for adults with unclassifiable interstitial lung disease (uILD). The designation was granted based on data from a Phase II trial, which studied the efficacy and safety of Esbriet in uILD
In March 2021, F. Hoffmann-La Roche Ltd, a biotech company, announced that the USA Food and Drug Administration (FDA) approved Actemra/RoActemra (tocilizumab) subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD), a debilitating condition with limited treatment options. Actemra/RoActemra is the first biologic therapy approved by the USA FDA for the treatment of the disease.

A Full Report Overview

Key Companies Profiled

Boehringer Ingelheim
Bristol-Myers Squibb
FibroGen
Hoffmann-La Roche Ltd
Pliant Therapeutics, Inc.
United Therapeutics
Vicore Pharma AB
Avalyn Pharmaceuticals
Beijing Continent Pharmaceutical
GNI-EPS Pharmaceuticals, Inc.

Key Segments Covered in the Progressive Fibrosing Interstitial Lung Disease (PFILD) Treatment Market Industry Survey

Progressive Fibrosing Interstitial Lung Disease (FLILD) Treatment Market by Drug Type:

Corticosteroids
Immune Suppressing
Anti-Fibrotic Medication
Others

Progressive Fibrosing Interstitial Lung Disease (FLILD) Treatment Market by Route of Administration:

Oral
Injectable

Progressive Fibrosing Interstitial Lung Disease (FLILD) Treatment Market by Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Progressive Fibrosing Interstitial Lung Disease (PFILD) Treatment Market by Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Enterprise Intellectual Property Management Software Market to Surpass US$ 38.68 Billion by 2033

The global Enterprise Intellectual Property (IP) Management Software Market for 2023 to 2033 is projected to experience remarkable growth, according to a new report. The market size is expected to rise from US$ 7,624.9 million in 2023 to an impressive US$ 38,684.6 million by 2033, reflecting a compound annual growth rate (CAGR) of 17.6% during the forecast period.

This surge in demand is attributed to the rapid technological advancements and increasing complexities in managing intellectual property across various industries, including healthcare, technology, and manufacturing. Organizations are now leveraging enterprise IP management software to streamline processes, ensure compliance, and protect valuable intellectual property assets.

Key Takeaways from the Market Study

The enterprise IP management software market is projected to reach US$ 38,684.6 million by 2033.
A robust CAGR of 17.6% is expected between 2023 and 2033.
Industries like healthcare, pharmaceuticals, and technology are major drivers of market growth.
The rise in patent filings and IP disputes globally has escalated the demand for efficient IP management solutions.

Picture background

Drivers and Opportunities
The enterprise intellectual property management software market is driven by the increasing need for effective IP management solutions as businesses prioritize innovation and product differentiation. The growing number of patents, trademarks, and copyrights filed globally necessitates efficient management and protection mechanisms, further fueling market demand.

Opportunities abound for market players to introduce AI-powered IP management solutions that enhance automation, reduce manual errors, and provide advanced analytics for better decision-making. The integration of blockchain technology to ensure secure and transparent IP transactions is also expected to create new opportunities for growth.

Components Insights
The enterprise IP management software market is segmented into software and services. The software segment is expected to dominate the market, driven by the increasing adoption of cloud-based platforms that offer scalability, data security, and easy access to real-time information. The services segment, which includes consulting and support, is also anticipated to grow steadily as organizations seek expert guidance on implementing and optimizing IP management systems.

Application Insights
The market serves a variety of applications, including patent management, trademark management, IP portfolio management, and IP litigation management. Patent management holds the largest share of the market, as organizations across industries are continuously innovating and filing new patents. IP portfolio management is also gaining traction as companies seek to optimize their IP assets and maximize their commercial potential.

Deployment Insights
Cloud-based solutions are gaining widespread adoption in the enterprise IP management software market due to their flexibility, scalability, and cost-efficiency. On-premise solutions remain relevant, particularly for large enterprises with specific data security requirements, but the trend is increasingly shifting towards cloud-based models.

Key Companies & Market Share Insights
Major players in the enterprise IP management software market include Clarivate Plc, Dennemeyer Group, Anaqua, Inc., IPfolio Corporation, and CPA Global. These companies are leading the charge with innovative solutions that cater to the evolving needs of businesses in managing their intellectual property portfolios. Many are focusing on integrating AI and machine learning to enhance the functionality of their platforms and offer predictive analytics to their clients.

Recent Developments

Clarivate Plc introduced new AI-driven features to its IP management software, helping businesses better predict patent expiry and renewal strategies.
Anaqua, Inc. partnered with leading global pharmaceutical firms to provide customized IP management solutions tailored to the industry’s regulatory complexities.
IPfolio Corporation expanded its cloud-based platform to integrate blockchain technology, ensuring secure and verifiable IP transactions.

With rapid advancements in industries such as pharmaceuticals, technology, and manufacturing, the need for robust IP management solutions is more critical than ever. The enterprise intellectual property management software market is poised for strong growth over the next decade, offering significant opportunities for innovation and investment.

About Future Market Insights (FMI)

Contact Us:

Global Transfusion Dependent Thalassaemia Management Market Expected to Reach USD 17.91 Million by 2033 at a 6% of CAGR, Fueled by Rising Awareness and Advancements in Treatment

The Transfusion Dependent Thalassaemia Management Market is set to garner a value of USD 10 Million in 2023, with projections indicating it will grow to USD 17.91 Million by 2033, reflecting a robust CAGR of 6% during the forecast period from 2023 to 2033. This growth follows a historical CAGR of 4% from 2018 to 2022, highlighting an increasing focus on the management and treatment of this genetic blood disorder.

Thalassemia, a hereditary condition affecting approximately 4.4 out of every 10,000 live births globally, results from inherited gene mutations that can affect both males and females equally, as it follows an autosomal pattern of inheritance. The rising prevalence of thalassemia, coupled with increasing awareness and advancements in therapeutic options, is driving the demand for effective management solutions. As research and innovation in treatment continue to evolve, the Transfusion Dependent Thalassaemia Management Market is positioned for significant growth in the coming years.

2018 to 2022 Transfusion Dependent Thalassaemia Management Market Demand Analysis vs. Forecast 2023 to 2033

According to market research and competitive intelligence provider Future Market Insights- the market for Transfusion Dependent Thalassaemia Management reflected a value of 4% during the historical period, 2018 to 2022.

A series of international-level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering effective ways for Transfusion Dependent Thalassaemia Management.

According to the National Center on Birth Defects and Developmental Disabilities, thalassemia affects at least 1,000 people in the United States of America. The market’s growth is also attributed to the factors such as growing disease prevalence, a rise in lifestyle-associated concerns, and technological advancements. Furthermore, the increasing incidence of thalassemia patients and increasing research and development investments are propelling immense growth.

In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights into key factors driving demand for Transfusion Dependent Thalassaemia Management. In the years to come, increasing focus by government organizations and private agencies like WHO and pharmaceutical companies to create awareness of thalassemia is fuelling market growth. Thus, the market for Transfusion Dependent Thalassaemia Management is expected to register a CAGR of 6% in the forecast period 2023 to 2033.

Market Competition

Key players in the Transfusion Dependent Thalassaemia Management Market are Celgene Corporation, BlueBird Bio, Protagonist Therapeutics, Agios Pharmaceuticals, Ionis Pharmaceuticals, Vifor Pharma, Sangamo Therapeutics, Orchard Therapeutics, CRISPR Therapeutics, and DisperSol Technologies among other global players.

In November 2022, the Centers for Disease Control and Prevention (CDC) launched a Thalassemia Healthcare Provider Resource Toolkit. This free toolkit is filled with free resources for providers caring for people living with thalassemia. It includes Continuing Medical Education Offerings and Webinars, Scientific Articles and Features, CDC Activities Related to Transfusion Complications in Thalassemia, Resources on Newborn Screening, Thalassemia Treatment Centers, Resources for Thalassemia Care, Treatment, and Management, and so on.
In August 2022, the USA Food and Drug Administration approved Zynteglo (Betibeglogene auto excel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.

Key Companies Profiled

Sigma-Aldrich. BD
Enzo Life Sciences
Creative Diagnostics
Thermo Fisher Scientific
Epitope Diagnostics Inc.
R&D Systems
QED Bioscience Inc
ACROBiosystems.

A Full Report Overview

Key Segments Profiled in the Transfusion Dependent Thalassaemia Management Industry Survey

Therapy:

Iron Chelating Drugs
Erythroid Maturation Agents
Stem Cell Therapy
Others

End-User:

Hospital
Homecare
Specialty Clinics
Others

Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Motorized Decoiler Machine Market Projected to Reach USD 4.8 Million by 2033, Driven by Technological Advances and Manufacturing Applications

The global motorized decoiler machine market is expected to be valued at USD 3.2 million in 2022, with strong demand anticipated throughout the assessment period. This growth is attributed to advancements in technology and increased applications in manufacturing, with projections indicating a market value of USD 4.8 million by 2033, reflecting a CAGR of 3.9% from 2023 to 2033. Additionally, the market is expected to reach USD 3.3 million in 2023.

The increase in worldwide production has made the global manufacturing industry a significant user of motorized decoiler machines, leading to heightened demand in the market.

These machines not only minimize the manual effort required for unrolling and straightening heavy metal reels but also enhance the feed rate for various machinery in use. Furthermore, as industries increasingly adopt automation, decoiler machines have become integral to manufacturing processes.

Key Takeaways

Over the past few years, a healthy increase can be seen in production industry which has led to the increased manufacturing demands for motorized decoiler machines worldwide.
It is not feasible to unroll and straighten heavy metal reels manually, so motorized decoilers are used as an alternative way to ease human effort. In addition, they are useful for feeding various machines in process at high rates. Growing automation in industries has made it possible to install decoilers in manufacturing facilities, propelling sales of motorized decoiler machines.
Decoiler machines come in different sizes with different configurations based on the material type, size and gauge, which is widely used in paper pulp, textile and metal production industries.
With the introduction of automation in decoiling machines, their reliability has improved, driving the growth of the motorized decoiler machine market. Motorized recoilers can handle heavy reel loads and provide high production rates.
North America and Europe are projected to remain dominant in decoiler machine installations with CAGRs of 17.0% and 15.0%, respectively. Metal consumption has increased significantly over the last two decades due to the global industrial production boom.

Competitive Landscape

Swi Engineering, The Formtek Group, Worcester Presses Ltd., Dongguan City Haiwei Intelligent Equipment Incorporated Company, Fabbrica Impianti Macchine Industriali S.p.A, Reef Engineering And Manufacturing Co. (Pty) Limited, Vaspo Vamberk, Ltd., Metalforming Inc., Wuxi Zhenqun Machinery Manufacture Co., Ltd., Acier Equipment, Bluesky Machine Co., Ltd., Jiaozuo Mengxin Special Steel Co., Ltd., Dongguan City Haiwei Intelligent Equipment Incorporated Company, Shanghai Baosheng Machinery Equipment Co. Ltd. are some of the key companies profiled in the full version of the report.

Some of the leading companies operating in the global motorized decoiler machine market are focusing on producing a wide range of high-capacity and precision levelers, sheet metal processing machines, deburring machines, and coil lines for manufacturers worldwide, propelling the growth of the motorized decoiler machine market.

Key Segments Profiled in the Motorized Decoiler Machine Market

By Operating Load:

less than 5 Ton (< 5 Ton)
5 ton to 10 Ton (5 Ton – 10 Ton)
above 10 Ton (> 10 tons)

By Number of Heads:

Single head
Dual Head
Multi Head

By Drive:

Electric
Hydraulic

By Material Stock:

Strip Decoilers
Sheet Decoilers
Wire/ Pipe Decoilers

By End Use Industry:

Machine and equipment manufacture
Automotive
HVAC and duct manufacturing
Stamping
Sheet steel processing industry
Others

By Region:

North America
Latin America
Western Europe
Eastern Europe
Asia-Pacific
Japan
Middle East and Africa

Report Preview: https://www.futuremarketinsights.com/reports/motorized-decoiler-machine-market

About Future Market Insights (FMI)

Contact Us:

Global Ringworm Treatment Market Expected to Reach USD 13.91 Billion in 2033 at a 5.2% of CAGR, Driven by High Prevalence of Skin Diseases

According to a newly-released analysis, the global ringworm treatment market is projected to reach a market value of US$ 8.38 Billion in 2023, with a forecasted CAGR of 5.2% over the period from 2023 to 2033. By the end of 2033, the market is expected to witness significant growth, driven by the increasing demand for effective treatments for ringworm and other skin diseases.

The high prevalence of skin conditions, particularly fungal infections such as ringworm, has led to an upsurge in demand for treatment solutions. The growing awareness of personal hygiene and advancements in dermatological treatments have also contributed to the market’s expansion. These factors are anticipated to continue driving growth throughout the forecast period, establishing the ringworm treatment market as a key segment within the global healthcare and pharmaceutical industries.

A fungal infection of the skin called dermatophytosis is on the rise for antifungal products such as creams, dusting powders, and oral medications. The incidence of ringworm may reach as high as 20% worldwide every year. It is more common for men to contract groin infections, while females are equally likely to contract scalp and body infections. Children are most likely to contract scalp infections, while the elderly are most likely to suffer from groin infections

FMI predicts that by 2023, the drug class segment will account for more than 3/5th of ringworm treatment sales. According to estimates, ultraviolet races will collectively hold more than half of the market share by 2032. Phototherapy utilizing ultraviolet light is highly popular in treating fungus infections on the skin, such as ringworm. Medical professionals in various developed regions use UV light therapy to treat affected skin areas, and the demand for these therapies has increased. Usually, this therapy takes a few weeks to complete in a series of treatments.

Competitive Landscape

The key players in the global ringworm treatment market are conducting research and development activities to develop new products as well as antifungal ointments for the diagnosis and treatment of ringworms. These new treatments are anticipated to launch in the near future. Obtaining approval for new products in a timely manner gives companies a competitive edge over competitors.

Bayer relaunches Canesten in the Indian market. Canesten cream, according to the company, helps treat fungal skin infections such as athlete’s foot, ringworm, jock itch, and skin candidiasis. Further, the formulation is effective in treating vulvovaginal candidiasis complicated by inflammatory lesions and skin fungal infections.
Close to 20,000 households will benefit from the Department of Health’s program on herbal medicine, which was launched through the Philippine Institute of Traditional and Alternative Health Care. PITAHC developed HerbMAP under the supervision of Undersecretary Charade Mercado-Grande in response to the occurrence of the pandemic, which worsened the lack of herbal medications and products.

Key Companies Profiled

Perrigo Company plc
Novartis AG
GlaxoSmithKline Plc
Teva Pharmaceuticals, Inc.
Taro Pharmaceutical Industries Ltd.
Glenmark Pharmaceuticals Inc.
Avik Pharma
Actiza Pharmaceutical
Chempro Group India
Merck & Co., Inc.

A Full Report Overview

Key Segments Profiled in the Ringworm Treatment Market Industry Survey?

By Drug Class:

Steroids
Antifungals
Anti-infective
Others

By Route of Administration:

Oral
Topical

By Distribution Channel:

Hospital Pharmacies
Drug Stores
Retailers
E-commerce

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Author By:

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Vertical Market Software Market Set to Surpass US$ 512.75 Billion by 2034

A newly released report on the Vertical Market Software Market for 2024 to 2034 forecasts significant growth over the next decade. The market size is expected to increase from US$ 152.80 billion in 2024 to US$ 512.75 billion by 2034, representing a robust compound annual growth rate (CAGR) of 12.9%.

Vertical market software, designed to cater to the specific needs of particular industries, has become increasingly vital as businesses continue to embrace digital transformation. The software streamlines operations, improves efficiency, and provides industry-specific functionalities, driving adoption across multiple sectors.

Key Takeaways from Market Study

The vertical market software market is projected to reach US$ 512.75 billion by 2034.
A steady CAGR of 12.9% is anticipated between 2024 and 2034.
The healthcare and financial services sectors are expected to drive significant demand for vertical market software.
Asia-Pacific is anticipated to witness the fastest growth, driven by rapid digitalization across key industries.

Drivers and Opportunities
The rise in industry-specific software solutions is fueled by the increasing need for specialized tools that address distinct operational requirements. From healthcare and retail to manufacturing and financial services, vertical market software is enabling businesses to scale effectively, automate workflows, and meet regulatory standards.

Opportunities for market players lie in offering customized solutions that are adaptable and scalable, as well as integrating cutting-edge technologies such as artificial intelligence (AI), machine learning (ML), and the Internet of Things (IoT). These innovations are expected to enhance the capabilities of vertical market software, unlocking new efficiencies and competitive advantages for users.

Components Insights
The vertical market software market is segmented into software and services. The software segment is anticipated to capture a dominant share, driven by the increasing demand for customizable and scalable software solutions tailored to specific industries. Meanwhile, the services segment, including consulting and support services, is expected to experience steady growth as businesses seek to optimize their software implementation.

Application Insights
Vertical market software finds applications across various industries, with healthcare, financial services, and retail leading the charge. The healthcare sector, in particular, is expected to drive notable growth, as hospitals and clinics rely more on electronic health record systems (EHRs) and telemedicine platforms. The financial services industry is also adopting specialized software to manage regulatory compliance, risk management, and data analytics.

Deployment Insights
The market is witnessing a shift toward cloud-based vertical market software solutions, which offer flexibility, scalability, and cost-effectiveness. On-premise solutions, while still in use by some organizations, are expected to see declining adoption as cloud-based deployments become the preferred option due to their lower infrastructure costs and faster implementation times.

Key Companies & Market Share Insights
Leading companies in the vertical market software market include Oracle Corporation, SAP SE, Microsoft Corporation, and Salesforce.com, Inc. These industry giants are investing heavily in research and development to provide innovative solutions that cater to specific industry needs. Strategic mergers and acquisitions, as well as partnerships with industry stakeholders, are common strategies employed by key players to expand their market presence.

Recent Developments

Oracle Corporation recently introduced an AI-powered suite of vertical market software tools, targeting the healthcare and retail sectors.
Microsoft Corporation has expanded its vertical market software offerings through strategic partnerships with financial institutions to provide cutting-edge solutions for risk management and compliance.
SAP SE announced the launch of a cloud-based platform for manufacturing that integrates AI and IoT, enhancing automation and operational efficiency.

As industries continue to digitalize and demand specialized software solutions, the vertical market software market is expected to grow rapidly, driven by technological advancements and increasing industry-specific needs.

About Future Market Insights (FMI)

Contact Us: